1.50
                                            Schlusskurs vom Vortag:
              $1.55
            Offen:
              $1.53
            24-Stunden-Volumen:
                297.72K
            Relative Volume:
              0.37
            Marktkapitalisierung:
                $46.48M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-42.37M
            KGV:
              -1.4037
            EPS:
                -1.0686
            Netto-Cashflow:
                $-34.94M
            1W Leistung:
              -6.83%
            1M Leistung:
              -68.42%
            6M Leistung:
                -33.04%
            1J Leistung:
              -73.02%
            Skye Bioscience Inc Stock (SKYE) Company Profile
Firmenname
                  
                      Skye Bioscience Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (858) 410-0266
                    
                Adresse
                  
                      11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
                    
                Vergleichen Sie SKYE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                SKYE
                            
                             
                        Skye Bioscience Inc. 
                           | 
                    3.10 | 12.89M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                MOBBW
                            
                             
                        Mobilicom Limited Warrants 
                           | 
                    3.17 | 4.40B | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                GOODO
                            
                             
                        Gladstone Commercial Corporation 
                           | 
                    19.96 | 372.90M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                SHMD
                            
                             
                        Schmid Group N V 
                           | 
                    5.05 | 189.47M | 0 | 0 | 0 | 0.00 | 
| 
                         
                          
                                PSNYW
                            
                             
                        Polestar Automotive Holding Uk 
                           | 
                    0.237 | 554.19M | 2.07B | -1.42B | -1.37B | -0.6765 | 
| 
                         
                          
                                DAVEW
                            
                             
                        Dave Inc 
                           | 
                    1.40 | 0 | 0 | 0 | 0 | 0.00 | 
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral | 
| 2025-10-06 | Herabstufung | Craig Hallum | Buy → Hold | 
| 2025-08-15 | Eingeleitet | Evercore ISI | Outperform | 
| 2025-02-28 | Eingeleitet | William Blair | Outperform | 
| 2024-09-30 | Eingeleitet | Scotiabank | Sector Outperform | 
| 2024-09-10 | Eingeleitet | JMP Securities | Mkt Outperform | 
| 2024-07-09 | Eingeleitet | Craig Hallum | Buy | 
| 2024-05-23 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2024-04-12 | Eingeleitet | Oppenheimer | Outperform | 
                    Alle ansehen
                    
                  
                Skye Bioscience Inc Aktie (SKYE) Neueste Nachrichten
Applying big data sentiment scoring on Skye Bioscience Inc.July 2025 Volume & Expert Approved Momentum Ideas - newser.com
Price action breakdown for Skye Bioscience Inc.GDP Growth & Weekly High Conviction Trade Ideas - newser.com
Live market analysis of Skye Bioscience Inc.Weekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Is Skye Bioscience Inc. (09R) stock a momentum leaderJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Is Skye Bioscience Inc. stock a defensive play in 2025Weekly Risk Report & Growth-Oriented Investment Plans - newser.com
How to integrate Skye Bioscience Inc. into portfolio analysis toolsProfit Target & AI Enhanced Trading Alerts - newser.com
Will Skye Bioscience Inc. (09R) stock outperform foreign stocksJuly 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com
Will Skye Bioscience Inc. stock go up soon2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
Why Skye Bioscience Inc. stock appeals to dividend seekersQuarterly Earnings Report & Expert Curated Trade Ideas - newser.com
Skye Bioscience Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Is Skye Bioscience Inc. forming a reversal patternInsider Selling & Weekly Return Optimization Plans - newser.com
Is Skye Bioscience Inc. still worth holding after the dipJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Volatility clustering patterns for Skye Bioscience Inc.Trade Exit Report & Safe Entry Zone Identification - newser.com
How Skye Bioscience Inc. stock reacts to inflationary pressuresMarket Weekly Review & Momentum Based Trading Ideas - newser.com
Can Skye Bioscience Inc. stock maintain growth trajectoryBuy Signal & Fast Exit/Entry Strategy Plans - newser.com
What technical models suggest about Skye Bioscience Inc.’s comeback - newser.com
How Skye Bioscience Inc. stock performs in weak economyFed Meeting & Daily Growth Stock Tips - newser.com
Intraday pattern recognizer results for Skye Bioscience Inc.GDP Growth & Weekly Market Pulse Updates - newser.com
Will Skye Bioscience Inc. (09R) stock keep raising dividendsJuly 2025 EndofMonth & Community Consensus Stock Picks - newser.com
Is Skye Bioscience Inc a good long term investmentCapital Gains Strategies & Rapid Portfolio Investment - earlytimes.in
Regression analysis insights on Skye Bioscience Inc. performanceGDP Growth & Weekly Market Pulse Alerts - newser.com
What analysts say about Skye Bioscience Inc stockSupport Zone Identification & Ride the Trends That Billionaires Follow - earlytimes.in
Will Skye Bioscience Inc. stock deliver consistent dividendsGold Moves & Fast Exit and Entry Strategy Plans - newser.com
How Skye Bioscience Inc. stock performs during Fed tightening cyclesRate Hike & Weekly Setup with ROI Potential - newser.com
Published on: 2025-10-30 23:45:10 - newser.com
Finanzdaten der Skye Bioscience Inc-Aktie (SKYE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Skye Bioscience Inc-Aktie (SKYE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt | 
|---|---|---|---|---|---|---|---|
| Schwab Andrew J. | Director  | 
                        Aug 21 '25  | 
                        Sale  | 
                        3.57  | 
                        60,956  | 
                        217,613  | 
                        63,963  | 
                    
| 5AM Partners VII, LLC | 10% Owner  | 
                        Aug 22 '25  | 
                        Sale  | 
                        3.42  | 
                        170,449  | 
                        582,936  | 
                        57,493  | 
                    
| 5AM Partners VII, LLC | 10% Owner  | 
                        Aug 21 '25  | 
                        Sale  | 
                        3.57  | 
                        60,956  | 
                        217,613  | 
                        63,963  | 
                    
| Diep Tuan Tu | Chief Development Officer  | 
                        Nov 18 '24  | 
                        Sale  | 
                        4.99  | 
                        19,489  | 
                        97,250  | 
                        82,259  | 
                    
| Diep Tuan Tu | Chief Development Officer  | 
                        Nov 15 '24  | 
                        Sale  | 
                        5.55  | 
                        85  | 
                        472  | 
                        101,748  | 
                    
| ARSENAULT KAITLYN | Chief Financial Officer  | 
                        Nov 18 '24  | 
                        Sale  | 
                        4.99  | 
                        43,206  | 
                        215,598  | 
                        166,342  | 
                    
| ARSENAULT KAITLYN | Chief Financial Officer  | 
                        Nov 15 '24  | 
                        Sale  | 
                        5.55  | 
                        190  | 
                        1,054  | 
                        209,548  | 
                    
| DHILLON PUNIT | Chief Executive Officer  | 
                        Nov 18 '24  | 
                        Sale  | 
                        4.99  | 
                        82,546  | 
                        411,905  | 
                        329,823  | 
                    
| DHILLON PUNIT | Chief Executive Officer  | 
                        Nov 15 '24  | 
                        Sale  | 
                        5.55  | 
                        364  | 
                        2,020  | 
                        412,369  | 
                    
| Grayson Paul A. | Director  | 
                        Nov 18 '24  | 
                        Sale  | 
                        4.99  | 
                        86,244  | 
                        430,358  | 
                        259,701  | 
                    
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):